Lynne V McFarland
Overview
Explore the profile of Lynne V McFarland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
3295
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masset Z, Gunaratnam S, Millette M, McFarland L, Lacroix M
Antibiotics (Basel)
. 2024 Apr;
13(4).
PMID: 38667041
infections (CDIs) continue to be a persistent healthcare concern despite newer antibiotic treatments, enhanced infection control practices, and preventive strategies focused on restoring the protective intestinal microbial barrier. Recent strides...
2.
Goff D, McFarland L, Johnson S, Goff D
Front Oral Health
. 2024 Jan;
4:1336565.
PMID: 38179437
No abstract available.
3.
McFarland L, Hecht G, Sanders M, Goff D, Goldstein E, Hill C, et al.
JAMA Netw Open
. 2023 Dec;
6(12):e2346872.
PMID: 38064222
Importance: Systematic reviews and meta-analyses often report conflicting results when assessing evidence for probiotic efficacy, partially because of the lack of understanding of the unique features of probiotic trials. As...
4.
McFarland L, Goldstein E, Kullar R
Microorganisms
. 2023 Jun;
11(6).
PMID: 37375036
infections (CDIs) have decreased in the past years, but since 2021, some hospitals have reported an increase in CDI rates. CDI remains a global concern and has been identified as...
5.
McFarland L, Srinivasan R, Setty R, Ganapathy S, Bavdekar A, Mitra M, et al.
JPGN Rep
. 2023 May;
2(3):e079.
PMID: 37205949
Pediatric acute gastroenteritis (PAGE) is a significant cause of morbidity, mortality and healthcare costs in many countries, but differences in PAGE vary from country-to-country; thus, we limited our analysis to...
6.
Kullar R, Goldstein E, Johnson S, McFarland L
Microorganisms
. 2023 Apr;
11(4).
PMID: 37110319
Lactobacilli are widely found in nature, are commensal microbes in humans, and are commonly used as probiotics. Concerns about probiotic safety have arisen due to reports of bacteremia and other...
7.
Masset Z, Gunaratnam S, Millette M, McFarland L, Lacroix M
J Appl Microbiol
. 2023 Mar;
134(3).
PMID: 36898672
Aims: Clostridioides difficile infections (CDI) are a major cause of morbidity and mortality in hospitalized patients. A probiotic formulation (Bio-K+) comprised of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacti....
8.
Altcheh J, Carosella M, Ceballos A, DAndrea U, Jofre S, Marotta C, et al.
Medicine (Baltimore)
. 2022 Sep;
101(36):e30500.
PMID: 36086703
Background: The choice of an appropriate probiotic for pediatric acute gastroenteritis (PAGE) can be confusing. Our aim was to compare the efficacy and safety of 2 probiotics (Saccharomyces boulardii CNCM...
9.
Mohr A, Pugh J, OSullivan O, Black K, Townsend J, Pyne D, et al.
Front Nutr
. 2022 Mar;
9:809983.
PMID: 35350412
Probiotic supplementation, traditionally used for the prevention or treatment of a variety of disease indications, is now recognized in a variety of population groups including athletes and those physically active...
10.
Callis Duffin K, Gladman D, Goel N, Gottlieb A, FitzGerald O, McFarland L
J Rheumatol
. 2022 Feb;
49(6 Suppl 1):1-3.
PMID: 35169061
The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) held its annual meeting in 2021 in an online format due to travel restrictions during the ongoing COVID-19...